Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left ...

There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

In a 2022 study ... Last year, Novo Nordisk's drug sales ballooned on prescriptions of both Wegovy and Ozempic for weight loss. Sales of Ozempic increased 77% to about $8.5 billion, and sales ...

By 2022, patients were starting to ask for Ozempic ... This unofficial system perpetuated the weight-loss drug trend through the shortages of 2023, allowing people to use weight-loss drugs even ...

Already in 2022, GLP-1 drugs accounted for 5 percent ... are prohibited from covering weight loss drugs. MassHealth began covering weight loss drugs when medically necessary in January 2024 ...

"These medications intended for diabetes and weight loss can help addiction without ... Over 75% of drug overdose deaths in 2022 involved opioids. If you or someone you know is living with ...

Medicines in a popular new class of weight loss drugs including Ozempic and WeGovy ... as a staff writer at The Week since September 2022. She frequently writes about technology, education ...

Weight-loss and diabetes drugs like Ozempic ... spanned January 2014 to September 2022. Researchers tracked these folks' use of GLP-1 drugs, as well as any bouts of intoxication or overdose ...

The drug uses the active ingredient tirzepatide and was approved by the FDA in May 2022 for type 2 diabetes ... GLP-1 drugs for the purpose of weight loss.She paid out-of-pocket for it instead ...